GSK3389404
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GSK3389404, covering 2018-08-01 to 2020-01-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3389404 in Chronic Hepatitis B (CHB) Subjects [Phase 2]